Katsuya Toshida

422 total citations
41 papers, 277 citations indexed

About

Katsuya Toshida is a scholar working on Surgery, Hepatology and Cancer Research. According to data from OpenAlex, Katsuya Toshida has authored 41 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 18 papers in Hepatology and 13 papers in Cancer Research. Recurrent topics in Katsuya Toshida's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Katsuya Toshida is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Katsuya Toshida collaborates with scholars based in Japan and United States. Katsuya Toshida's co-authors include Tomoharu Yoshizumi, Shinji Itoh, Noboru Harada, Yoshihiro Nagao, Takeo Toshima, Takahiro Tomiyama, Takeshi Kurihara, Norifumi Iseda, Takahiro Tomino and Akinari Morinaga and has published in prestigious journals such as SHILAP Revista de lepidopterología, Transplantation and Annals of Surgical Oncology.

In The Last Decade

Katsuya Toshida

37 papers receiving 276 citations

Peers

Katsuya Toshida
Lei Cai China
Katsuya Toshida
Citations per year, relative to Katsuya Toshida Katsuya Toshida (= 1×) peers Lei Cai

Countries citing papers authored by Katsuya Toshida

Since Specialization
Citations

This map shows the geographic impact of Katsuya Toshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuya Toshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuya Toshida more than expected).

Fields of papers citing papers by Katsuya Toshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuya Toshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuya Toshida. The network helps show where Katsuya Toshida may publish in the future.

Co-authorship network of co-authors of Katsuya Toshida

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuya Toshida. A scholar is included among the top collaborators of Katsuya Toshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuya Toshida. Katsuya Toshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toshida, Katsuya, Shinji Itoh, Yuki Nakayama, et al.. (2025). Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 32(10). 8037–8045.
2.
Toshima, Takeo, Shinji Itoh, Yoshihiro Nagao, et al.. (2024). What is the crux of successful living‐donor liver transplantation for recipients aged 70 and beyond?. Annals of Gastroenterological Surgery. 8(4). 668–680.
3.
Ishikawa, Takuma, Shinji Itoh, Takeo Toshima, et al.. (2024). A successful case of deceased-donor liver transplantation from a donor with Marfan syndrome: a case report. SHILAP Revista de lepidopterología. 10(1). 14–14.
4.
Toshida, Katsuya, Shinji Itoh, Takeo Toshima, et al.. (2024). Association of serum lactate dehydrogenase with prognosis and tumor metabolism in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab therapy. Surgery Today. 55(3). 370–379. 1 indexed citations
5.
Yoshiya, Shohei, Shinji Itoh, Takeo Toshima, et al.. (2024). Is preoperative weight reduction of living-donor liver transplant recipients and donors harmful to postoperative outcomes?. Journal of Gastrointestinal Surgery. 28(7). 1033–1038. 1 indexed citations
6.
Toshima, Takeo, Shinji Itoh, Kazutoyo Morita, et al.. (2024). Feasibility of venous cuff using an open round ligament or inferior mesenteric vein around the hepatic vein for a left lobe graft in living-donor liver transplantation. Surgery Today. 54(7). 812–816. 1 indexed citations
7.
Toshida, Katsuya, Norifumi Iseda, Takahiro Tomiyama, et al.. (2024). The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis. Liver Cancer. 14(1). 1–22. 6 indexed citations
8.
Toshida, Katsuya, Shinji Itoh, Noboru Harada, et al.. (2023). Transferrin Receptor is Associated with Sensitivity to Ferroptosis Inducers in Hepatocellular Carcinoma. Annals of Surgical Oncology. 30(13). 8675–8689. 24 indexed citations
9.
Toshida, Katsuya, Shinji Itoh, Yukiko Kosai‐Fujimoto, et al.. (2023). Preoperative HALP score is a prognostic factor for intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection: association with sarcopenia and immune microenvironment. International Journal of Clinical Oncology. 28(8). 1082–1091. 8 indexed citations
10.
Yoshiya, Shohei, Noboru Harada, Takeo Toshima, et al.. (2023). Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: Focusing on the Japan criteria. Surgery Today. 54(1). 64–72. 5 indexed citations
11.
Tomiyama, Takahiro, Shinji Itoh, Norifumi Iseda, et al.. (2023). Clinical Significance of Signal Regulatory Protein Alpha (SIRPα) Expression in Hepatocellular Carcinoma. Annals of Surgical Oncology. 30(6). 3378–3389. 9 indexed citations
12.
Tomino, Takahiro, Noboru Harada, Katsuya Toshida, et al.. (2023). Effect of Early Enteral Nutrition on Graft Loss After Living Donor Liver Transplantation: A Propensity Score Matching Analysis. Transplantation Proceedings. 55(9). 2164–2170. 2 indexed citations
13.
Tomiyama, Takahiro, Rigel Suzuki, Noboru Harada, et al.. (2023). A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients. Frontiers in Cellular and Infection Microbiology. 13. 1197349–1197349. 4 indexed citations
14.
Toshida, Katsuya, Shinji Itoh, Yukiko Kosai‐Fujimoto, et al.. (2023). Association of gut microbiota with portal vein pressure in patients with liver cirrhosis undergoing living donor liver transplantation. JGH Open. 7(12). 982–989. 2 indexed citations
15.
Toshida, Katsuya, Shinji Itoh, Noboru Harada, et al.. (2022). Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma. Cancer Science. 114(3). 937–947. 12 indexed citations
16.
Tomiyama, Takahiro, Shinji Itoh, Katsuya Toshida, et al.. (2022). A rare case of unresectable, microsatellite instability-high hepatocellular carcinoma and an examination of the tumor microenvironment. International Cancer Conference Journal. 12(1). 81–86. 1 indexed citations
17.
Tomiyama, Takahiro, Noboru Harada, Takeo Toshima, et al.. (2022). Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study. Transplant International. 35. 10723–10723. 3 indexed citations
18.
Toshida, Katsuya, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2021). Retrospective evaluation of the effect of Ninjin’yoeito in hepatocellular carcinoma patients treated with lenvatinib. Surgery Today. 52(3). 441–448. 5 indexed citations
19.
Toshida, Katsuya, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2021). Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report. Clinical Journal of Gastroenterology. 14(5). 1459–1463. 6 indexed citations
20.
K, Oda, et al.. (1951). Chemotherapy of malignant tumor.. PubMed. 42(2-4). 269–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026